AIMEI HEALTH TECHNOLOGY CO., LTD
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-83.1K | $45.4K | $98.1K | $352.0K | $425.0K | $184.7K | $444.1K | $743.5K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-156.9K | $-74.6K | $-43.2K | $-96.1K | $-201.8K | $-224.0K | $-195.1K | $-53.9K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-103.0K | $-68.7K | $33.7M | $-450.0K | $-450.0K | $30.8M | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $242.8K | $158.9K | $-33.6M | $547.0K | $646.5K | $-30.6M | — | — |
| Net Change in Cash | $-17.1K | $15.6K | $-50 | $841 | $-5.2K | $-20.9K | $-75.4K | $-53.9K |
| Free Cash Flow | — | — | — | — | — | — | — | — |